Caffeine’s anti-inflammatory effects may help protect blood vessels

A new paper in Rheumatology, published by Oxford University Press, finds that consuming more caffeine may improve heart health.

Europe’s TCR immunotherapy licensing deals surge in 2024

Licensing agreement deal values for innovator T-cell receptor (TCR) immunotherapy drugs for European biopharmaceutical companies increased by 325% (by $921 million) between 2023 to 2024

November 22, 2024

Why a new health tech venture firm is investing only in founders with a healthcare background

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Create Health Ventures … Sign up to

August 14, 2024

Rush to DOACs Spells Trouble for Frail Warfarin Users

AMSTERDAM — Best let frail older people who are stable on international normalized ratio (INR)-guided vitamin K antagonist (VKA) management stay on it instead of

August 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.